David Levison
Organization leader
Who is David Levison?
David is CEO of CardioDx and a Venture Partner at TPG Ventures. He was formerly interim CEO of XDx. Previously, he was the founder, President and CEO of iScribe (which was sold to AdvancePCS-now Caremark in December, 2001). Prior to iScribe, David was President of Oncology Therapeutics Network (sold to Bristol-Myers Squibb in 1996). David also served as CFO of OTN's parent company, Axion, from 1990 to 1993. Prior to Axion, he was with Cole Gilburne Fund, an early stage, technology focused venture capital firm. David received his MBA from Stanford University and BS from WilliamsCollege.
We need you!
Help us build the largest biographies collection on the web!
- Education
- MBA, Stanford Graduate School of Business
- Bachelor of Science, Williams College
- Employment
- Chief Executive Officer, CardioDX
- Venture Partner, TPG Capital
- Interim Chief Executive Officer, XDx, Inc.
- President and CEO, IScribe
( - 2001) - President, Oncology Therapeutics Network
( - 1996) - Chief Financial Officer, Axion Inc.
(1990 - 1993) - Cole Gilburne Fund
Submitted
on July 23, 2013
Citation
Use the citation below to add to a bibliography:
Style:MLAChicagoAPA
"David Levison." Biographies.net. STANDS4 LLC, 2024. Web. 29 Apr. 2024. <https://www.biographies.net/people/en/david_levison>.
Discuss this David Levison biography with the community:
Report Comment
We're doing our best to make sure our content is useful, accurate and safe.
If by any chance you spot an inappropriate comment while navigating through our website please use this form to let us know, and we'll take care of it shortly.
Attachment
You need to be logged in to favorite.
Log In